| 发明名称 |
Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor |
| 摘要 |
The use of diphenylionodonium (DPI) in the preparation of a medicament for activating and protecting cytotoxic lymphocytes in the presence of monocytes (MO); the medicament may further comprise a compound that inhibits the production or release of intercellular reactive oxygen species (ROM). |
| 申请公布号 |
NZ515859(A) |
申请公布日期 |
2004.02.27 |
| 申请号 |
NZ20000515859 |
申请日期 |
2000.07.14 |
| 申请人 |
MAXIM PHARMACEUTICALS, INC |
发明人 |
HELLSTRAND, KRISTOFFER;HERMODSSON, SVANTE;GEHLSEN,KURT R |
| 分类号 |
A61K45/00;A61K31/03;A61K31/352;A61K31/417;A61K31/519;A61K31/7068;A61K38/00;A61K38/19;A61K38/21;A61K38/44;A61K39/00;A61K39/39;A61K45/06;A61P31/12;A61P35/00;A61P37/04;A61P43/00 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
